INS and type 2 diabetes mellitus: In our previous studies, over 50% of adults with newly diagnosed type 2 diabetes mellitus (mean HbA1c 9.7%–10%) obtained 1‐year remission after SIIT, accompanied by improvement in β‐cell function and insulin sensitivity [7, 8].